Financings

Company NameAmount RaisedType of FundraiseCountryDate
Private company financings
Maze Therapeutics$115 millionSeries DUS3 December
Antag Therapeutics$84 millionSeries ADenmark4 December
Nuvig Therapeutics$161 millionSeries BUS5 December
Citryll$89.8 millionSeries BThe Netherlands9 December
Tasca Therapeutics$52 millionSeries ABoston10 December
Angitia Biopharmaceuticals$120 millionSeries CUS11 December
Veradermics$75 millionSeries BUS11 December
SiteOne Therapeutics$100 millionSeries CUS18 December
Ottimo Pharma$140 millionSeries AUK19 December
Bluenote$10 millionSeedUS19 December
Syncromune$100 millionSeries AUS20 December
AusperBio$73 millionSeries BUS26 December
Orbis$93 millionSeries ADenmark6 January
Maze Therapeutics$115 millionSeries DUS7 January
Prudentia Sciences$7 millionSeedUS8 January
Tenvie Therapeutics$200 millionUndisclosed SeriesUS8 January
Aspect Biosystems$115 millionSeries BCanada8 January
Alesta Therapeutics$67 millionSeries ANetherlands8 January
Verdiva Bio$411 millionSeries AUK9 January
Coave Therapeutics$33 millionSeries AFrance9 January
Light Horse$62 millionSeries AUS9 January
A2 Biotherapeutics$80 millionSeries CUS9 January
Timberlyne$180 millionSeries AUS10 January
Ouro Medicines$120 millionSeries AUS10 January
Kardigan$300 millionSeries AUS10 January
Windward$200 millionSeries AIsrael10 January
Tune Therapeutics$175 millionSeries BUS12 January
Normunity$75 millionSeries BUS13 January
Umoja Biopharma$100 millionSeries CUS14 January
Micron Biomedical$16 millionSeries A ExtensionUS16 January
Helicore Biopharma$65 millionSeries AUS28 January
Atalanta Therapeutics$97 millionSeries BUS28 January
Public company financings
Protara Therapeutics$100 millionCMPOUS9 December
Rocket Pharmaceuticals$189 millionCMPOUS11 December
NewAmsterdam Pharma$479 millionFollow-on fundraiseNetherlands11 December
ImmunityBio$115 millionCMPOUS11 December
CG Oncology$238 millionFollow-on fundraiseUS12 December
Candel Therapeutics$92 millionCMPOUS12 December
INOVIO Pharmaceuticals$30 millionCMPOUS13 December
AEON Biopharma$20 millionCMPOUS6 January
uniQure N.V.$75 millionCMPOUS8 January
Amylyx Pharmaceuticals$60 millionCMPOUS10 January
Compass Pathways$150 millionUnderwritten offeringUK10 January